Table 3. Maximum doping substance intake and doping control risk Supplement Weight maximum daily dose Compound (class) Contamination calculation Positive doping control threshold Estimated potential risk B5 1.5 g higenamine 1.5 µg 10 µg NO 2017 F1 15 g BMPEA †  NBDMPEA †  Oxilofrine †  0.39 g 15 mg 0.17 g 50 µg 50 µg 50 µg YES YES YES F3 20 g BMPEA †  NBDMPEA †  Oxilofrine †  0.98 g 0.48 g 0.80 g 50 µg 50 µg 50 µg YES YES YES G2 3.0 g Endogenous AAS (1) higenamine oxilofrine testosterone 3.0 µg 3.0 µg 3.0 µg 3.0 µg 1 mg 10 µg 50 µg 1 mg NO NO 2017 NO NO G3 3.0 g cathine ephedrine methylephedrine oxilofrine †  strychnine testosterone 3.0 µg 3.0 µg 3.0 µg 0.17 g 3.0 µg 3.0 µg 5 mg 10 mg 10 mg 50 µg 50 µg 1 mg NO NO NO YES NO NO H23 4.8 g Endogenous AAS (6) ephedrine higenamine 29 µg 4.8 µg 4.8 µg 1 mg 10 mg 50 µg NO NO NO 2017 O2 4.8 g higenamine 4.8 µg 10 µg NO 2017 Q1 89 g DMBA oxilofrine 89 µg 89 µg 50 µg 50 µg YES YES † = high level finding, 2017 = before September 2017 this product was estimated to potentially cause a positive doping test, 3=this product contained 3 components which were tested separately